Low Carbon Innovation Fund 2 invests in Ablatus Therapeutics

▤ Summary

Turquoise, the UK merchant bank specialising in energy, environment and efficiency, has invested in Ablatus Therapeutics for the Low Carbon Innovation Fund 2 (LCIF2). The investment of \xa385,000 is part of an overall round which could reach \xa31.5 million.Ablatus Therapeutics is developing Bimodal Electric Tissue Ablation (BETA), an innovative improvement over existing tissue ablation techniques, in order to offer greater clinical options and to improve patient outcomes.In order to read the full story we need you to be registered with us, please click the links below to login or register.

▦ Linked Companies